WASHINGTON--(BUSINESS WIRE)--The Fasano Longevity Conference, which will be held on November 5th in Washington, DC, will include a broad range of topics bearing on longevity markets.
Washington insider, Kevin Madden, will give his take on the Impact of the Mid-Term Elections. Kevin will be followed by Coventry CEO, Alan Buerger, who will share his insights on the State of the Life Settlement Industry. The morning sessions will also feature a presentation by Securis Investment Partners with their analysis of the Relative Values in Life Settlement and Structured Settlement Markets, as well as the opportunities to come with Synthetic Structures; and will finish with an analysis by Dr. Steven Rigatti of the Different Methods of Measuring Biologic Age.
The afternoon sessions will feature some very interesting, original research from two great academic institutions. Northwestern University’s Dr. Thomas Meade will present the results of their efforts to Disable Cancer Cells from Metastasizing; and Drs. Kent Smetters and Felix Reichling of the Wharton School will analyze the Impact of Medicare Reform on Longevity.
The afternoon agenda will finish with James Atkins’ Critique of Pricing in the Secondary Structured Settlement Market and with an all-star panel who will cover the Impact of New Privacy Regulations in both the U.S. and the European Union.
Said Michael Fasano, President of Fasano Associates, "This year's Conference has something for everyone - from politics to breakthrough medical research." Fasano described his Conference as "Investor Focused." He added: "What sets our Conference apart is that we are able to get longevity experts with fresh perspectives who can combine relevant experience with truly original research."
The Fasano Conference is a one-day event, with cocktails and dinner following the presentations. With a registration fee of only $495 and eight original presentations, Fasano characterized his Conference as "the best value in the business."
About Fasano Associates:
Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.
